Covered recipient · General Payments record
SHEETAL MALIK
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$166,181.71
- Reported across 200 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Honoraria | $13,475.00 | 5 |
| Travel and Lodging | $550.78 | 3 |
| Food and Beverage | $466.42 | 8 |
| Education | $51.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| SK Life Science, Inc. | $14,401.08 | 15 |
| NEUROPACE, INC. | $125.39 | 1 |
| ABBVIE INC. | $16.73 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.73 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104943754 | CMS |
| NEUROPACE, INC. | $125.39 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153275020 | CMS |
| SK Life Science, Inc. | $5,775.00 | 01/26/2024 | Honoraria | Undisputed | 01/23/2026 | 1154111285 | CMS |
| SK Life Science, Inc. | $23.06 | 01/26/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1154111287 | CMS |
| SK Life Science, Inc. | $34.00 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154111291 | CMS |
| SK Life Science, Inc. | $34.00 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154111399 | CMS |
| SK Life Science, Inc. | $6.49 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154111289 | CMS |
| SK Life Science, Inc. | $51.00 | 03/07/2024 | Education | Undisputed | 01/23/2026 | 1154111363 | CMS |
| SK Life Science, Inc. | $550.00 | 03/22/2024 | Honoraria | Undisputed | 01/23/2026 | 1154111421 | CMS |
| SK Life Science, Inc. | $11.22 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154111319 | CMS |
| SK Life Science, Inc. | $1,100.00 | 05/31/2024 | Honoraria | Undisputed | 01/23/2026 | 1154111423 | CMS |
| SK Life Science, Inc. | $220.86 | 10/10/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1154111401 | CMS |
| SK Life Science, Inc. | $306.86 | 10/10/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1154111403 | CMS |
| SK Life Science, Inc. | $121.48 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154111405 | CMS |
| SK Life Science, Inc. | $3,850.00 | 10/10/2024 | Honoraria | Undisputed | 01/23/2026 | 1154111419 | CMS |
| SK Life Science, Inc. | $117.11 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154111409 | CMS |
| SK Life Science, Inc. | $2,200.00 | 11/14/2024 | Honoraria | Undisputed | 01/23/2026 | 1154111417 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.